Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Novartis
Company Monitoring Page for Novartis
latest headlines for company on cafepharma
Spark licenses blindness gene therapy rights outside U.S. to Novartis
Yahoo/Reuters
Thu, 01/25/18 - 12:00 am
Tags:
Spark Therapeutics
,
Novartis
,
Luxturna
,
gene therapy
Novartis (NVS) Q4 Earnings & Sales Top on Cosentyx, Entresto
NASDAQ.com
Wed, 01/24/18 - 08:10 pm
Tags:
Novartis
,
earnings
,
Cosentyx
,
Entresto
Big day looming, Novartis’ new CEO Vas Narasimhan readies his jump into a marketing melee
Endpoints
Wed, 01/24/18 - 09:16 am
Tags:
Novartis
,
Pharma CEOs
,
Vas Narasimhan
,
Joe Jimenez
Novartis, feeling the heat from head-to-head rivals, pulls Arzerra outside the U.S.
Fierce Pharma
Mon, 01/22/18 - 05:41 pm
Tags:
Novartis
,
Arzerra
,
Genmab
,
CLL
,
chronic lymphocytic leukemia
Novartis ties a new round of biosimilar development programs to a partnership deal with India’s Biocon
Endpoints
Thu, 01/18/18 - 10:35 pm
Tags:
Novartis
,
Biocon
,
drug development
,
biosimilars
Novartis aims for US approval of Humira biosimilar
Biopharma Dive
Wed, 01/17/18 - 09:55 pm
Tags:
Novartis
,
Humira
,
biosimilars
,
AbbVie
,
Sandoz
Novartis goes 2-0 against J&J in psoriasis
Biopharma Dive
Wed, 01/17/18 - 11:36 am
Tags:
Novartis
,
JNJ
,
psoriasis
,
Cosentyx
,
Stelara
Novartis Starts Trial on Psoriasis Drug Cosentyx Biosoimilar
Yahoo/Zacks.com
Wed, 01/10/18 - 10:18 am
Tags:
Novartis
,
psoriasis
,
Cosentyx
,
biosimilars
,
ankylosing spondylitis
Novartis Pharma Ex-CEO takes three roles in two days
Pharmafile
Sat, 01/6/18 - 12:36 pm
Tags:
Novartis
,
Pharma CEOs
,
David Epstein
,
Axcella Health
,
Rubius
Cancer Space Update: New Regulatory Status for 3 Major Drugs
Yahoo/Zacks.com
Fri, 01/5/18 - 05:33 pm
Tags:
cancer
,
Merck
,
Japan
,
Keytruda
,
Seattle Genetics
,
Adcetris
,
Novartis
,
Kisqali
Pfizer, Novartis and more post price hikes on dozens of drugs, but AbbVie’s is worth the most
Fierce Pharma
Thu, 01/4/18 - 10:27 pm
Tags:
drug pricing
,
Pfizer
,
Novartis
,
AbbVie
Novartis Gets Second Breakthrough Designation for Kisqali
Yahoo/Zacks.com
Thu, 01/4/18 - 09:50 pm
Tags:
Novartis
,
Kisqali
,
breast cancer
Top 10 stories that had pharma execs talking
Biopharma Dive
Thu, 01/4/18 - 12:02 pm
Tags:
M&A
,
Bristol-Myers Squibb
,
Opdivo
,
Express Scripts
,
Novartis
,
C-ART
,
Kymriah
,
Massachusetts
,
AbbVie
,
Kenneth Frazier
,
biosimilars
,
CVS Health Pfizer
Ruling Against Novartis Could Have Wider Implications for Generic Drug Labels
RAPS.org
Sat, 12/23/17 - 11:58 am
Tags:
Novartis
,
generics
,
California
Kymriah, Yescarta found ‘cost-effective’ in treating cancer, despite high price
Endpoints
Thu, 12/21/17 - 10:12 am
Tags:
Kymriah
,
Yescarta
,
CAR-T
,
Novartis
,
Kite Pharma
,
Gilead Sciences
,
drug pricing
P&G investors wish for CEO Joe Jimenez as outgoing Novartis chief joins board
Fierce Pharma
Tue, 12/19/17 - 10:20 am
Tags:
P&G
,
Novartis
,
Pharma CEOs
,
Joe Jimenez
What’s the big hurry Novartis? Pharma giant scores a PRV shortcut for $130M
Endpoints
Mon, 12/18/17 - 10:02 am
Tags:
Novartis
,
priority review vouchers
,
Ultragenyx
Pfizer takes on Novartis, Lilly with Xeljanz psoriatic arthritis approval
Fierce Pharma
Fri, 12/15/17 - 11:27 pm
Tags:
Pfizer
,
Novartis
,
Eli Lilly
,
Xeljanz
,
psoriatic arthritis
Novartis oncology CEO Bruno Strigini is calling it quits
Endpoints
Fri, 12/15/17 - 10:09 am
Tags:
Novartis
,
oncology
,
Bruno Strigini
ASH 2017: What you missed
BioPharma Dive
Wed, 12/13/17 - 06:35 pm
Tags:
ASH17
,
Biomarin
,
Spark Therapeutics
,
Gilead Sciences
,
Novartis
,
Juno Therapeutics
,
AbbVie
,
Roche
,
JNJ
Pages
« first
‹ previous
…
60
61
62
63
64
65
66
67
68
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.